Related Experiment Video
Updated: Jun 14, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.0K
Stopping runaway seizures with a chill pill
1University of Iowa, Carver College of Medicine, Iowa City, United States.
Elife
|September 5, 2024
Summary
Neurotensin, a neuropeptide, can mitigate status epilepticus by inducing therapeutic hypothermia. This effect is achieved when neurotensin is delivered via a molecule capable of crossing the blood-brain barrier.
Area of Science:
- Neuroscience
- Pharmacology
- Critical Care Medicine
Background:
- Status epilepticus (SE) is a neurological emergency with severe consequences.
- Current treatments for SE have limitations and associated risks.
- Therapeutic hypothermia shows promise in neuroprotection but faces delivery challenges.
Purpose of the Study:
- To investigate the potential of neurotensin to induce therapeutic hypothermia for treating status epilepticus.
- To explore the use of a blood-brain barrier-penetrating molecule for neurotensin delivery.
Main Methods:
- Utilizing a novel molecule designed to cross the blood-brain barrier.
- Conjugating neurotensin to this molecule for targeted delivery.
- Assessing the induction of therapeutic hypothermia and its effects on SE models.
Main Results:
- The neurotensin-bound molecule successfully penetrated the blood-brain barrier.
- Induction of therapeutic hypothermia was achieved.
- Reduction in status epilepticus severity and associated consequences was observed.
Conclusions:
- Neurotensin, when delivered across the blood-brain barrier via a suitable carrier molecule, can effectively induce therapeutic hypothermia.
- This approach offers a promising new strategy for managing status epilepticus and its detrimental effects.
Related Concept Videos
01:17Antiepileptic Drugs: Calcium Channel Blockers
347
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
347
01:08Antiepileptic Drugs: Sodium Channel Blockers
459
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
459
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
349
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
349
01:24Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
01:19Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315
01:14Antiepileptic Drugs: Glutamate Antagonists
300
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
300